Weight management

被引:2
作者
Caterson, Ian D. [1 ]
机构
[1] Univ Sydney, Human Nutr Unit, Sydney, NSW, Australia
关键词
obesity; orlistat; sibutramine;
D O I
10.18773/austprescr.2006.027
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Obesity treatment is effective and moderate weight losses can be maintained for 4-5 years. Even small weight losses are effective in preventing diabetes, improving the control of diabetes and improving the cardiovascular risk profile. They also improve mobility, sleep apnoea and general well-being. There is a place for pharmacotherapy but drugs must be used in conjunction with a behavioural change (lifestyle) program. Pharmacotherapy (currently orlistat and sibutramine are available) used for 2-4 years can help to maintain weight loss, but the ideal duration of such therapy is uncertain. When pharmacotherapy is ceased some weight will be regained. This regain generally results in the weight increasing to the weight that would have been achieved by effective lifestyle programs. Other therapies such as very low calorie diets and obesity surgery also produce long-term successful weight loss.
引用
收藏
页码:43 / 47
页数:5
相关论文
共 26 条
  • [1] [Anonymous], 2003, CLIN PRACT GUID MAN
  • [2] Topiramate: Long-term maintenance of weight loss induced by a low-calorie diet in obese subjects
    Astrup, A
    Caterson, I
    Zelissen, P
    Guy-Grand, B
    Carruba, M
    Levy, B
    Sun, X
    Fitchet, M
    [J]. OBESITY RESEARCH, 2004, 12 (10): : 1658 - 1669
  • [3] AusDiab Steering Committee, 2001, DIAB ASS DIS AUSTR 2
  • [4] Barba C, 2004, LANCET, V363, P157, DOI 10.1016/S0140-6736(03)15268-3
  • [5] The epidemiology of overweight and obesity among Australian children and adolescents, 1995-97
    Booth, ML
    Wake, M
    Armstrong, T
    Chey, T
    Hesketh, K
    Mathur, S
    [J]. AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH, 2001, 25 (02) : 162 - 169
  • [6] Ditschuneit HH, 1999, AM J CLIN NUTR, V69, P198
  • [7] Metabolic and weight loss effects of long-term dietary intervention in obese patients: Four-year results
    Flechtner-Mors, M
    Ditschuneit, HH
    Johnson, TD
    Suchard, MA
    Adler, G
    [J]. OBESITY RESEARCH, 2000, 8 (05): : 399 - 402
  • [8] Weight loss with sibutramine improves glycaemic control and other metabolic parameters in obese patients with type 2 diabetes mellitus
    Fujioka, K
    Seaton, TB
    Rowe, E
    Jelinek, CA
    Raskin, P
    Lebovitz, HE
    Weinstein, SP
    [J]. DIABETES OBESITY & METABOLISM, 2000, 2 (03) : 175 - 187
  • [9] Herman WH, 2003, DIABETES CARE, V26, P36
  • [10] Role of orlistat in the treatment of obese patients with type 2 diabetes - A 1-year randomized double-blind study
    Hollander, PA
    Elbein, SC
    Hirsch, IB
    Kelley, D
    McGill, J
    Taylor, T
    Weiss, SR
    Crockett, SE
    Kaplan, RA
    Comstock, J
    Lucas, CP
    Lodewick, PA
    Canovatchel, W
    Chung, J
    Hauptman, J
    [J]. DIABETES CARE, 1998, 21 (08) : 1288 - 1294